Chinese Premier Li Qiang presented a concise Government Work Report at the Second Session of the 14th National People’s Congress (NPC) on March 5. The report outlined key focuses for the biomedicine sector, emphasizing the acceleration of innovation to stimulate economic recovery. This includes advancements in cutting-edge fields such as hydrogen energy, new materials, and innovative drugs, as well as the cultivation of new growth engines in biological manufacturing, commercial aerospace, and the low-altitude economy.
The report also detailed plans to deepen reforms in social and livelihood sectors, including income distribution, social security, healthcare, and elderly care services. There is a commitment to enhance medical and health service capabilities and to intensify safety supervision over food, drugs, and special equipment.
The government’s ongoing efforts in the prevention and control of key infectious diseases were highlighted, with an increase in the per capita financial subsidy standard for resident medical insurance by RMB 30. The report pledged continued coordinated development and governance across medical insurance, healthcare, and medicine sectors. This includes provincial-level coordination of Basic Medical Insurance (BMI) schemes, improvements to the national centralized drug procurement system, strengthened supervision of medical insurance fund usage, and measures to facilitate insured medical treatment for patients outside their home province.
The reform of public hospitals will be deepened, focusing on patient-centric care and the promotion of mutual recognition of examination and testing results. Tiered diagnosis and treatment will be promoted to bring high-quality medical resources to grassroots levels, enhancing the coordination and linkage of county-level and rural medical services. The government also aims to expand the types of drugs used for chronic and common diseases in grassroots medical and health institutions. There will be an acceleration of new services in pediatrics, geriatric care, mental health, and medical care. Support for traditional Chinese medicines will continue, and the Healthy China Initiative will be furthered.- Flcube.com
